Skip to content
stockmarketcap
Discover
Top gainersTop losersMost activeMarket sectorsHeatmapTreasury rates
Earnings calendarIPO calendarEx-dividend calendarEconomic calendar
Congress tradesInsider tradesAnalyst upgrades & downgrades
Collections
ScreenerCompareBacktester
ValuationFundamentals
WatchlistPortfolioPricing
Sign in
Markets
StocksGainersLosersMost activeMarket sectorsHeatmapEarnings calendarCongress tradesInsider tradesAnalyst upgrades/downgradesIPO calendarEx-dividend calendar
Tools
ScreenerCompare stocksReturns backtesterPortfolio trackerWatchlistEmbeddable widget
Metrics
ValuationFundamentals
Popular lists
Best dividend stocksBest value stocksLargest companiesLowest P/E stocks
Collections
All lists & collectionsUS stocksJapanese stocksChinese stocksHong Kong stocksSouth Korean stocksTaiwanese stocksCanadian stocksUK stocksEuropean stocksMagnificent 7AI stocksSemiconductor stocks
Compare
Compare stocksFinviz alternativeKoyfin alternativeTradingView alternativeStockAnalysis alternative
Learn
Investing glossaryHelp & guide
StockMarketCapDocsTokenTermsPrivacyData for information only, not investment advice.
◆

ABBV vs MRK

AbbVie Inc. and Merck & Co., Inc. compared side by side. Customize this comparison

Performance (normalized)

-8%+25%+59%+92%+126%stockmarketcap.io

Key metrics

MetricABBV logoABBVMRK logoMRK
Price$261.07$129.52
Market cap$461.26B$319.89B
P/E ratio (TTM)123.28x36.07x
P/S ratio (TTM)7.07x4.84x
Dividend yield2.68%2.62%
Beta0.310.22
1-year return+36.87%+57.25%

Want return correlation and up to five stocks side by side? The advanced compare tool is part of Plus.